Cancer Research Grants  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheung, H. W.
Right arrow Articles by Wang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, H. W.
Right arrow Articles by Wang, X.
[Cancer Research 65, 1450-1458, February 15, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets and Chemical Biology

Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells

Hiu Wing Cheung1, Dong-Yan Jin2, Ming-tat Ling1, Yong Chuan Wong1, Qi Wang1, Sai Wah Tsao1 and Xianghong Wang1

Departments of 1 Anatomy and 2 Biochemistry, Faculty of Medicine, University of Hong Kong, Hong Kong, China

Requests for reprints: Xianghong Wang, Department of Anatomy, University of Hong Kong, 1/F, Faculty of Medicine Building, 21 Sassoon Road, Hong Kong, China. Phone: 852-2819-2867; Fax: 852-2817-0857; E-mail: xhwang{at}hkucc.hku.hk.

Recently, mitotic arrest deficient 2 (MAD2)–mediated spindle checkpoint is shown to induce mitotic arrest in response to DNA damage, indicating overlapping roles of the spindle checkpoint and DNA damage checkpoint. In this study, we investigated if MAD2 played a part in cellular sensitivity to DNA-damaging agents, especially cisplatin, and whether it was regulated through mitotic checkpoint. Using nine nasopharyngeal carcinoma (NPC) cell lines, we found that decreased MAD2 expression was correlated with cellular resistance to cisplatin compared with the cell lines with high levels of MAD2. Exogenous MAD2 expression in NPC cells also conferred sensitivity to DNA-damaging agents especially cisplatin but not other anticancer drugs with different mechanisms of action. The increased cisplatin sensitivity in MAD2 transfectants was associated with mitotic arrest and activation of apoptosis pathway evidenced by the increased mitotic index and apoptosis rate as well as decreased Bcl-2 and Bax ratio and expression of cleaved poly(ADP-ribose) polymerase and caspase 3. Our results indicate that the MAD2-induced chemosensitization to cisplatin in NPC cells is mediated through the induction of mitotic arrest, which in turn activates the apoptosis pathway. Our evidence further confirms the previous hypothesis that spindle checkpoint plays an important part in DNA damage-induced cell cycle arrest and suggests a novel role of MAD2 in cellular sensitivity to cisplatin.

Key Words: MAD2 • cisplatin • sensitivity • apoptosis • cell cycle checkpoints • mechanisms of drug action/new molecular target/therapeutics • cell cycle mechanisms of anticancer drug action • effectors of apoptosis




This article has been cited by other articles:


Home page
JEMHome page
E. Y.-W. Choy, K.-L. Siu, K.-H. Kok, R. W.-M. Lung, C. M. Tsang, K.-F. To, D. L.-W. Kwong, S. W. Tsao, and D.-Y. Jin
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival
J. Exp. Med., October 27, 2008; 205(11): 2551 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al.
Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Xu, H. Peng, Q. Chen, Y. Liu, Z. Dong, and J.-T. Zhang
Oligomerization Domain of the Multidrug Resistance-Associated Transporter ABCG2 and Its Dominant Inhibitory Activity
Cancer Res., May 1, 2007; 67(9): 4373 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. W. Cheung, A. C.S. Chun, Q. Wang, W. Deng, L. Hu, X.-Y. Guan, J. M. Nicholls, M.-T. Ling, Y. Chuan Wong, S. Wah Tsao, et al.
Inactivation of Human MAD2B in Nasopharyngeal Carcinoma Cells Leads to Chemosensitization to DNA-Damaging Agents.
Cancer Res., April 15, 2006; 66(8): 4357 - 4367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.